GSE62843,GSE64371 2 V 5 FURAN MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE62843,GSE64371 2 V 5 FURAN MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE62843,GSE64371 2 V 5 FURAN MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE62843,GSE64371 2 V 5 FURAN MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE62843,GSE64371 2 V 5 FURAN MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

ribosomal protein S18

Gene

H2A clustered histone 19

Gene

CDGSH iron sulfur domain 3

Gene

ribonuclease P subunit p21

Gene

transmembrane protein 276

Gene

aldehyde dehydrogenase 1 family member L1

Gene

serpin family A member 10

Gene

component of oligomeric golgi complex 4

Gene

WD repeat containing planar cell polarity effector

Gene

protein Z, vitamin K dependent plasma glycoprotein

  • Gene

    ribosomal protein S18


  • Gene

    H2A clustered histone 19


  • Gene

    CDGSH iron sulfur domain 3


  • Gene

    ribonuclease P subunit p21


  • Gene

    transmembrane protein 276


  • Gene

    aldehyde dehydrogenase 1 family member L1


  • Gene

    serpin family A member 10


  • Gene

    component of oligomeric golgi complex 4


  • Gene

    WD repeat containing planar cell polarity effector


  • Gene

    protein Z, vitamin K dependent plasma glycoprotein

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.